ABVC BioPharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $11.6M
Liabilities Breakdown FY2020
Total Liabilities: $8.9M
Asset Breakdown
Total Assets: $11.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.3M | 36.8% |
| Accounts Receivable | $159.7K | 1.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $514.8K | 4.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.7M | 57.4% |
Liabilities Breakdown
Total Liabilities: $8.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $23.0K | 0.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.9M | 99.7% |